Genotype, Metabotype and Diet in a Cohort of Children and Adolescents From the Southeast of Spain.
NCT ID: NCT03318042
Last Updated: 2017-10-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
423 participants
INTERVENTIONAL
2016-02-01
2016-11-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The volunteers (n=423) with ages ranging from 5 to 18 years consumed for three days a daily serving of walnuts (30g) and provided a sample of urine (to determine mirobial-derived metabolites from walnut polyphenols) as well as a swab specimen from the inner cheek to provide DNA for further genotyping.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Child-teenagers-walnuts-pomegranate
Intake of walnuts or pomegranate juice for 3 days
Walnuts
The group consumed a daily serving of walnuts (30 g) or 200 mL pomegranate juice for 3 days and provided a sample of urine as well as a swab specimen from the inner cheek
Pomegranate juice
Those volunteers who were allergic to nuts consumed 200 mL pomegranate juice daily for 3 days and provided a sample of urine as well as a swab specimen from the inner cheek
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Walnuts
The group consumed a daily serving of walnuts (30 g) or 200 mL pomegranate juice for 3 days and provided a sample of urine as well as a swab specimen from the inner cheek
Pomegranate juice
Those volunteers who were allergic to nuts consumed 200 mL pomegranate juice daily for 3 days and provided a sample of urine as well as a swab specimen from the inner cheek
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent signed by the parent / legal representative, and by volunteers who are already 18 years old.
Exclusion Criteria
* Intake of antibiotics 1 month before the start of the study.
* If the participant could perceive stress or psychological damage due to his participation.
* Any other circumstance different from previous ones (illness, etc.), according to which it is considered that the intervention in the study may involve some type of affectation.
5 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CEIP (primary school) Jara Carrillo (Alcantarilla, Murcia, Spain)
UNKNOWN
IES (secondary school) Alcántara (Alcantarilla, Murcia, Spain)
UNKNOWN
IMDEA Food
OTHER
National Research Council, Spain
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Juan Carlos Espín de Gea
Research Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juan C. Espin, PhD
Role: PRINCIPAL_INVESTIGATOR
Spanish National Research Council (CSIC)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cebas-Csic
Murcia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AGL2015-64124-R(1)
Identifier Type: -
Identifier Source: org_study_id